These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17401594)

  • 1. Supplier-induced demand: re-examining identification and misspecification in cross-sectional analysis.
    Peacock SJ; Richardson JR
    Eur J Health Econ; 2007 Sep; 8(3):267-77. PubMed ID: 17401594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplier-induced demand: reconsidering the theories and new Australian evidence.
    Richardson JR; Peacock SJ
    Appl Health Econ Health Policy; 2006; 5(2):87-98. PubMed ID: 16872250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is health care really a luxury?
    Blomqvist AG; Carter RA
    J Health Econ; 1997 Apr; 16(2):207-29. PubMed ID: 10169095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A re-examination of the meaning and importance of supplier-induced demand.
    Labelle R; Stoddart G; Rice T
    J Health Econ; 1994 Oct; 13(3):347-68. PubMed ID: 10138860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An econometric analysis of health care expenditure: a cross-section study of the OECD countries.
    Gerdtham UG; Søgaard J; Andersson F; Jönsson B
    J Health Econ; 1992 May; 11(1):63-84. PubMed ID: 10119757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of supplier induced demand in the health care sector.
    Auster RD; Oaxaca RL
    J Hum Resour; 1981; 16(3):327-42. PubMed ID: 7264294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some economic aspects of the demand for health services.
    Sorkin AL
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Nov; 5(11):610-20. PubMed ID: 2699334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The demand for OTC medicines: some Australian evidence.
    Johnson LW
    Asia Pac J Public Health; 1991; 5(3):228-35. PubMed ID: 1823806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician supply, supplier-induced demand and competition: empirical evidence from a single-payer system.
    Xirasagar S; Lin HC
    Int J Health Plann Manage; 2006; 21(2):117-31. PubMed ID: 16846104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A re-examination of the meaning and importance of supplier-induced demand.
    Pauly MV
    J Health Econ; 1994 Oct; 13(3):369-72. PubMed ID: 10138861
    [No Abstract]   [Full Text] [Related]  

  • 11. More physicians: improved availability or induced demand?
    Carlsen F; Grytten J
    Health Econ; 1998 Sep; 7(6):495-508. PubMed ID: 9809708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the relative fee structure on the use of surgical operations.
    Escarce JJ
    Health Serv Res; 1993 Oct; 28(4):479-502. PubMed ID: 8407339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled cross-section analysis of the health care expenditures of the OECD countries.
    Gerdtham UG; Søgaard J; Jönsson B; Andersson F
    Dev Health Econ Public Policy; 1992; 1():287-310. PubMed ID: 10172496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New estimates of elasticity of demand for healthcare in rural China.
    Zhou Z; Su Y; Gao J; Xu L; Zhang Y
    Health Policy; 2011 Dec; 103(2-3):255-65. PubMed ID: 22014842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Econometric analyses of national health expenditures: can positive economics help to answer normative questions?
    McGuire A; Parkin D; Hughes D; Gerard K
    Health Econ; 1993 Jul; 2(2):113-26. PubMed ID: 8261033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Federalism and regional health care expenditures: an empirical analysis for the Swiss cantons.
    Crivelli L; Filippini M; Mosca I
    Health Econ; 2006 May; 15(5):535-41. PubMed ID: 16389663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new test for supplier-inducement and application to the Canadian market for dental care.
    Schaafsma J
    J Health Econ; 1994 Dec; 13(4):407-31. PubMed ID: 10140532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care expenditure and income in Europe.
    Murillo C; Piatecki C; Saez M
    Health Econ; 1993 Jul; 2(2):127-28. PubMed ID: 8261034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the economics of moral hazard need to be revisited? A comment on the paper by John Nyman.
    Blomqvist A
    J Health Econ; 2001 Mar; 20(2):283-8. PubMed ID: 11252375
    [No Abstract]   [Full Text] [Related]  

  • 20. The determinants and effects of health expenditure in developed countries.
    Hitiris T; Posnett J
    J Health Econ; 1992 Aug; 11(2):173-81. PubMed ID: 10122977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.